Cargando…
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
INTRODUCTION: Uncovering safety signals through the collection and assessment of individual case reports remains a core pharmacovigilance activity. Despite the widespread use of disproportionality analysis in signal detection, recommendations are lacking on the minimum size of databases or subsets o...
Autores principales: | Caster, Ola, Aoki, Yasunori, Gattepaille, Lucie M., Grundmark, Birgitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165139/ https://www.ncbi.nlm.nih.gov/pubmed/32008183 http://dx.doi.org/10.1007/s40264-020-00911-w |
Ejemplares similares
-
Is Omalizumab Related to Ear and Labyrinth Disorders? A Disproportionality Analysis Based on a Global Pharmacovigilance Database
por: Park, Hyeon Tae, et al.
Publicado: (2022) -
Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis
por: Hlavaty, Alex, et al.
Publicado: (2022) -
Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
por: Khouri, Charles, et al.
Publicado: (2021) -
Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database
por: Martín, Luis H., et al.
Publicado: (2022) -
Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database
por: Revol, Bruno, et al.
Publicado: (2022)